MAY 24 2006
510(K) Summary
Submitter: Cynosure, Inc.
10 Elizabeth Drive du
Chelmsford, MA 01824 Kos | aw
Contact: George Cho
Senior Vice President of Medical Technology

Date Summary Prepared: June 1, 2005

Device Trade Name: PhotoSilk Plus Pulsed Light System and Laser Attachment

Common Name: Pulsed Light System.

Laser: Er: YAG laser, Nd:YAG laser, Q-Switched Nd:YAG laser.

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.4810

Equivalent Device: StarLux Pulsed Light System, CO3 Er:YAG laser, ESC Nd:YAG
Accessory, and Medlite C6 Q-Switched Nd:YAG laser

Device Description: The PhotoSilk Plus Pulsed Light System and Laser Attachment
provides 400-1200nm pulsed light, 2,940nm Er:YAG, 1064nm
Nd:YAG and 1064nm Q-Switched Nd:YAG wavelengths. Laser
emission activation is by foot switch. Electrical requirement is 220
VAC, 20A, 50-60 Hz, single phase.

Intended Use: The PhotoSilk Plus Pulsed Light System is intended for permanent
hair reduction, and the treatment of vascular and pigmented lesions,
facial and leg veins, and inflammatory acne.

The PhotoSilk Plus Pulsed Light System Laser Attachment is intended
for:

2,940 nm - for skin resurfacing and for the incision, excision, ablation
or vaporization of soft bodily tissues.

1,064 nm - for treatment of benign cutaneous vascular lesions,
pigmented lesions, and hair removal.

QS 1,064 nm - for tattoo removal, and the treatment of pigmented
lesions.

Comparison: The PhotoSilk Plus Pulsed Light System and Laser Attachment have
very similar indications for use, the same principle of operation, and
similar performance specifications as the predicate devices.

Nonclinical Performance Data: none \

Clinical Performance Data: none

Conclusion: The PhotoSilk Plus Pulsed Light System and Laser Attachment is a
safe and effective device for the indications specified.

Additional Information: none

{ .
oy
i Ma DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
rook Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
MAY 2 4 2006
Cynosure, Inc.
% Mr. George Cho
Senior Vice President
5 Carlisle Road
Westford, Massachusetts 01886
Re: K051442
Trade/Device Name: Cynosure PhotoSilk Plus Pulsed Light System Laser Attachment
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and
in dermatology
, Regulatory Class: II
Product Code: GEX
Dated: February 2, 2006
Received: February 3, 2006
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
. You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class HI (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean ,
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set

1 2
Page 2 — Mr. George Cho :
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. oe
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
: other general information on your responsibilities under the Act from the Division of Small

Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain.html

ad) zine ;

Mark N. Melkerson

Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
: Enclosure

i J
,
510(k) Number (ifknown): {XK QO SI4Q XR ©
Device Name: _ Cynosure PhotoSilk Plus Pulsed Light System Laser Attachment
Indications For Use: 7
The PhotoSilk Plus Pulsed Light System is intended for permanent hair reduction and the treatment of
dermatological vascular lesions, facial and leg veins, benign pigmented lesions, and inflammatory acne.
: The PhotoSilk Plus Pulsed Light System Laser Attachment is intended for: ;
Er: YAG 2,940 nm - for skin resurfacing and for the incision, excision, ablation or vaporization of soft
bodily tissues.
Long Pulse Nd:YAG 1,064 nm - for the treatment of vascular lesions, pigmented lesions, wrinkles and
- for permanent hair reduction..
: Q-Switched Nd:YAG 1,064 nm - for dark tattoo removal, and the treatment of pigmented lesions.
Prescriptive Use D4 OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (Part 21 CFR 801 Subpart C)
: (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division SignDivision of General, Restorative,
and Neurological Devices
510(k) Number koS(4u2

